Disease Profiles Flashcards
Diabetes: Symptoms of High Blood Glucose - Urinary Tract (4)
Polyuria
Thirst
Polydypsia
Genital thrush
Diabetes: Symptoms of High Blood Glucose - General (3)
Blurred vision - altered osmotic pressure in the anterior chamber of the eye
Fatigue
Weight loss
Diabetes: Investigations - Blood glucose threshold is set by what?
Retinopathy risk
Diabetes: Investigations - Blood glucose in gestational diabetes is set by what?
Risk to the foetus or neonate
Diabetes: Investigations - Fasting Glucose thresholds
> 7.0 mmol/L
Diabetes: Investigations - Random or 2 hour glucose in OGTT threshold
> 11.1 mmol/L
Diabetes: Investigations - HbA1c threshold
> 48mmol/mol
HbA1c: What happens when Hb becomes exposed to glucose?
Glycated
HbA1c: Extent of glycation is proportional to what?
Glucose concentration
HbA1c: Level gives a representation of glucose exposure for how long?
90 days
HbA1c: Must analyse cautiously in what situations?
Increased or Reduced RBC turnover
Type I Diabetes Mellitus
Autoimmune destruction of the pancreatic beta cells resulting in Beta cell deficiency and therefore absolute insulin deficiency
Type I Diabetes Mellitus: Average age of onset
<20 years old
Type I Diabetes Mellitus: High incidence in what countries? (2)
Scandinavia
Saudi Arabia
Type I Diabetes Mellitus: This is more commonly diagnosed in what sex post-puberty?
Males
Type I Diabetes Mellitus: Aetiologies - Genetic cause
HLA Complex - DR3-DQ2 or DR4-DQ8
Type I Diabetes Mellitus: Aetiologies - Peak age of onset
10-14 years
Type I Diabetes Mellitus: Environmental Risk Factors - Maternal factors (2)
Older in age
Gestational infection
Type I Diabetes Mellitus: Environmental Risk Factors - Example of a viral infection
Coxsackie B4
Idiopathic Type I Diabetes Mellitus
Patients with permanent insulinopenia and are prone to DKA but have no evidence of Beta Cell Autoimmunity
Latent Autoimmune Disease in Adults
Late onset Type I Diabetes Mellitus
Type I Diabetes Mellitus: Pathophysiology - Autoantibodies present (4)
Glutamic Acid Decarboxylase (GAD-65)
Islet-antigen 2
IAA
ZnT8 Transporter (ZnT8Ab)
Type I Diabetes Mellitus: Pathophysiology - What immune response mediates this?
T-cell mediated autoimmune response with production of autoantibodies to target and destroy Beta Cells
Type I Diabetes Mellitus: Pathophysiology - What is visible on a Beta Cell Biopsy?
Insulitis with lymphocytic infiltrate
Type I Diabetes Mellitus: Clinical Presentation - Onset
Acute
Type I Diabetes Mellitus: Clinical Presentation - Urinary Tract Symptoms (3)
Polydypsia
Polyuria
Thrush
Type I Diabetes Mellitus: Clinical Presentation - General symptoms (4)
Weakness
Fatigue
Blurred vision
Severe weight loss
Type I Diabetes Mellitus: Diagnosis - Biochemical markers (5)
Increased glucose
Ketones
Decreased insulin
Decreased beta cell mass
Decreased C peptide
Type I Diabetes Mellitus: Insulin Management - Examples of Insulin Analogues
Insulin Aspart, Lispro or Glulisine
Type I Diabetes Mellitus: Insulin Management - Onset of insulin analogues
10-15 minutes
Type I Diabetes Mellitus: Insulin Management - Peak action of insulin analogues
60-90 minutes
Type I Diabetes Mellitus: Insulin Management -Duration of action of insulin analogues
4-5 hours
Type I Diabetes Mellitus: Insulin Management - Examples of soluble insulin
Actrapid or Humulin S
Type I Diabetes Mellitus: Insulin Management - Onset of action of Soluble Insulin
30-60 minutes
Type I Diabetes Mellitus: Insulin Management - Peak action of Soluble insulin
2-4 hours
Type I Diabetes Mellitus: Insulin Management - Duration of Soluble Insulin
5-8 hours
Type I Diabetes Mellitus: Isophane Basal insulin - Examples (2)
Insulatard
Humulin I
Type I Diabetes Mellitus: Isophane Basal insulin - Peak action
4-6 hours
Type I Diabetes Mellitus: Isophane Basal insulin - Duration
12 hours
Type I Diabetes Mellitus: Analogue Basal insulin - Examples (2)
Glargine
Detemir
Type I Diabetes Mellitus: Pancreas Transplantation - Options (2)
Kidney-pancreas auto-transplantation
Islet autotransplantation
Type I Diabetes Mellitus: Pancreas Transplantation - Indications (3)
Imminent End Stage Renal Disease
Severe hypoglycaemia or metabolic complications
Uncontrolled diabetes despite maximum treatment
Type I Diabetes Mellitus: Pancreas Transplantation - How are islets infued?
Into the portal vein to be transferred to the liver
Type I Diabetes Mellitus: Pancreas Transplantation - Immunosuppression options (2)
Mycophenalate
Tacrolimus
Type I Diabetes Mellitus: Associated Conditions (3)
Cystic Fibrosis
Wolfram Syndrome
Bardet-Biedl Syndrome
Type I Diabetes Mellitus: Pancreas Transplantation - Cystic Fibrosis DM Screening
OGTT from the age of 10
Type I Diabetes Mellitus: Pancreas Transplantation - Cystic Fibrosis DM Management
Insulin
Type I Diabetes Mellitus: Pancreas Transplantation - Wolfram Syndrome DM clinical presentation (3)
DI or DM
Optic atrophy
Deafness
Type I Diabetes Mellitus: Pancreas Transplantation - Bardet-Biedl Syndrome DM Clinical presentation (4)
Obesity
Polydactyly
Hypogonadism
Visual impairments
Type I Diabetes Mellitus: Complications - Microvascular complications are largely driven by what?
Hyperglycaemia
Type I Diabetes Mellitus: Complications - Examples of microvascular complications (3)
Retinopathy
Neuropathy
Nephropathy
Type I Diabetes Mellitus: Complications - Examples of Macrovascular complications (4)
Myocardial infarction
ACS
Stroke
Peripheral Vascular Disease
Type I Diabetes Mellitus: Complications - Macrovascular complications are due to what? (3)
Hyperglycaemia
Hypertension
Dyslipidaemia
Type I Diabetes Mellitus: Retinopathy - 4 types
Diabetic retinopathy
Diabetic macular oedema
Cataracts
Glaucoma
Type I Diabetes Mellitus: Retinopathy - Cataract
Clouding of the lens
Type I Diabetes Mellitus: Retinopathy - Glaucoma
Increase in fluid in the eye to cause optic nerve damage due to increased pressure
Type I Diabetes Mellitus: Retinopathy Grading - R1 Features and Monitoring
Mild Background Diabetic Retinopathy - microaneurysms, flame exudates, >4 blot haemorrhages and cotton wool spots
Monitoring - rescreen in 12 months
Type I Diabetes Mellitus: Retinopathy Grading - R2
Moderate Background Diabetic Retinopathy - >4 blot haemorrhages in one hemifield
Monitoring - Rescreen in 12 months
Type I Diabetes Mellitus: Retinopathy Grading - R3
Severe non-proliferative or pre-proliferative Diabetic Retinopathy - >4 blot haemorrhages in both hemifields with intraretinal microvascular anolies and venous beading
Monitoring - Refer
Type I Diabetes Mellitus: Retinopathy Grading - R4
Proliferative Retinopathy - Vitreous haemorrhage, Retinal detachment and Neovascularisation
Monitoring - Refer
Type I Diabetes Mellitus: Retinopathy - Cotton wool spots indicate wht?
Areas of ischaemia
Type I Diabetes Mellitus: Retinopathy - Intra-retinal microvascular abnormalities are a precursor to what?
Neovascularisation
Type I Diabetes Mellitus: Retinopathy - Maculopathy
Hard exudate with 1 disc diameter of the fovea
Type I Diabetes Mellitus: Retinopathy - 3 options for management
Lasers
Vitrectomy
Intra-vitreal Anti-VEGF
Type I Diabetes Mellitus: Retinopathy - Laser management mechanism
Pan retinal photocoagulation - Reduces the oxygen requirement of the retina to reduce ischaemia
Type I Diabetes Mellitus: Retinopathy - Vitrectomy used when?
If a vitreal haemorrhage is present
Type I Diabetes Mellitus: Retinopathy - Management for Macular Oedema
Intra-viteal Anti-VEGF
Type I Diabetes Mellitus: Diabetic Nephropathy
Progressive kidney disease caused by damage to the capillaries of the kidney glomeruli characterised by proteinuria and diffuse scarring of the glomeruli
Type I Diabetes Mellitus: Diabetic Nephropathy -Complocations (3)
Hypertension
Decline in renal function
Accelerated vascular disease
Type I Diabetes Mellitus: Diabetic Nephropathy -Measure what to analyse urine protein?
Protein:Creatinine Ratio
Type I Diabetes Mellitus: Diabetic Nephropathy -Proteinuria diagnostic
ACR<PCR
Type I Diabetes Mellitus: Microalbuminuria - Urinary Albumin Excretion Rate varies with what factors (4)
Exercise
Protein load
Fluid load
Time of day
Type I Diabetes Mellitus: Microalbuminuria - Urinary Albumin Excretion Rate False positives (5)
Menstruation
Vaginal discharge
UTI
Pregnancy
Non-diabetic renal disease
Type I Diabetes Mellitus: Diabetic Nephropathy - Management First Line
ACEI or ARB
Type I Diabetes Mellitus: Diabetic Nephropathy - Blood pressure target
<140/80 mmHg
Type I Diabetes Mellitus: Diabetic Nephropathy - Glucose target for management
53 mmol/mol
Type I Diabetes Mellitus: Diabetic Neuropathy - Peripheral
Distal symmetric or Sensorimotor Pain or loss of feeling in the feet or hands
Type I Diabetes Mellitus: Diabetic Neuropathy - Proximal
Pain in the thighs, hips or bottom leading to weakness in the legs
Type I Diabetes Mellitus: Diabetic Neuropathy - Autonomic
Changes in automatic functions
Type I Diabetes Mellitus: Diabetic Neuropathy - Focal
Sudden weakness in one nerve or a group of nerves causing muscle weakness or pain
Type I Diabetes Mellitus: Peripheral Neuropathy - Symptoms (5)
Numbness or insensitivity
Tingling or burning
Sharp pains or cramps
Sensitivity to touch
Loss of balance or coordination
Type I Diabetes Mellitus: Peripheral Neuropathy - Charcot Foot
Destructive inflammatory process with fractures and bony destruction causing deformity to the foot
Type I Diabetes Mellitus: Peripheral Neuropathy - Charcot Foot Presentation
Hot swollen foot in someone with neuropathy
Type I Diabetes Mellitus: Peripheral Neuropathy - Charcot Foot Management
Non-weight bearing and total contact cast
Type I Diabetes Mellitus: Peripheral Neuropathy - Oral Management Options (4)
Amitryptyline
Duloxetine
Gabapentin
Pregabalin
Type I Diabetes Mellitus: Peripheral Neuropathy - Topical Management Option
Capsaicin cream
Type I Diabetes Mellitus: Proximal Neuropathy -Clinical Presentation (3)
Pain in the thighs, hips, bottom or legs on one side
Proximal muscle weakness
Marked weight loss
Type I Diabetes Mellitus: Autonomic Neuropathy - Digestive System Presentation (3)
Gastric slowing and reduced frequency of movement - constipation and diarrhoea
Gastroparesis - reduced speed of gastric emptying
Oesophageal nerve damage - dysphagia and weight loss
Type I Diabetes Mellitus: Autonomic Neuropathy - Symptoms on impact on sweating
Profuse sweating at night or whilst eating
Type I Diabetes Mellitus: Autonomic Neuropathy - Treatment for Excess Sweating (3)
Topical Glycopyrrolate
Clonidine
Botulinum Toxin
Type I Diabetes Mellitus: Mononeuropathy - Examples (2)
VI Cranial Nerve Palsy
Carpal Tunnel Syndrome
Type I Diabetes Mellitus: Mononeuropathy - VI Cranial Nerve Palsy
Abducens cranial nerve causes inability to abduct the eye
Type II Diabetes Mellitus: Onset
Middle aged adults and elderly
Type II Diabetes Mellitus
Impaired glucose control due to increased insulin resistance and insulin deficiency
Type II Diabetes Mellitus: Aetiologies (5)
Obesity
Sedentary Lifestyle
Family History
Pregnancy
Calorie-dense diet
Type II Diabetes Mellitus: What ethnicities are at a greater risk? (3)
South asian
African
Afro-carribean
Type II Diabetes Mellitus: Abnormalities of Insulin Action - How does central obesity like to this?
Increased plasma levels of FFA causes impaired insulin-dependent glucose uptake into hepatocytes, myocytes and adipocytes
Type II Diabetes Mellitus: Abnormalities of Insulin Action - What role does increased tyrosine kinase have in this?
Decreased activation of downstream pathways causing decreased GLUT channel expression and decreased cellular glucose uptake
Type II Diabetes Mellitus: Abnormalities of Insulin Secretion - Early sign is loss of what?
Normal biphasic insulin secretion
Type II Diabetes Mellitus: Abnormalities of Insulin Secretion - What is toxic to Beta Cells in this? (2)
Increased FFAs and Adipokines
Type II Diabetes Mellitus: Onset
Gradual onset
Type II Diabetes Mellitus: Clinical signs
Acanthosis nigricans - insulin driven epithelial overgrowth
Type II Diabetes Mellitus: Clinical presentation
Obesity
Standard - polyuria, polydypsia and fatigue
Type II Diabetes Mellitus: HbA1c threshold
<7% or 53mmol.mol
Type II Diabetes Mellitus: HbA1c threshold for patients on triple oral therapy or insulin
58 mmol/mol
Type II Diabetes Mellitus: First line management
Lifestyle management + Metformin
Type II Diabetes Mellitus: Management - Diabetics with Atherosclerotic CVD
Metformin + GLP-1 Receptor Antagonist
Type II Diabetes Mellitus: Management - Diabetics with HF or CKD
Metformin + SGLT2 Inhibitors (GLP-1 antagonist second line)
MODY
Maturity Onset Diabetes of the Young
MODY: Definition
Early onset (<25 years old) of non-insulin dependent diabetes
MODY: Aetiology
Single gene mutation
MODY: 3 types of mutation (3)
Glucokinase
Transcription factors
MODY X
MODY: Glucokinase Mutations Pathophysiology
Activity impairment results in glucose sensing defect, causing an increase in the threshold for insulin secretion
MODY: Transcription Factor Mutations - Main mutations (3)
HNF-1-alpha
HNF-1-Beta
HNF-4-alpha
MODY: Clinical Presentation - Glucokinase Mutation onset and presentation
Onset at birth
Stable hyperglycaemia
MODY: Clinical Presentation - Transcription factor mutation onset and presentation
Adolescent onset
Progressive hyperglycaemia
MODY: Diagnosis - Main test
Oral Glucose Tolerance Test
MODY: Diagnosis - OGTT Glucokinase Mutations result
High fasting blood glucose but brings glucose down with oral challenge
MODY: Diagnosis - OGTT Transcription Factor Mutations result
Normal fasting blood glucose with bad response to glucose challenge
Neonatal Diabetes: Main aetiology
Monogenic mutation
Neonatal Diabetes: Pathophysiology
Mutations within the K-ATP Channel - mainly Kir6.2 mutations
Neonatal Diabetes: Diagnosis - Timeframe
<6 months
Neonatal Diabetes: Diagnosis - Clinical presentation (4)
Polydypsia
Polyuria
Dehydration
DKA
Neonatal Diabetes: Management
Sulphonylureas - inhibit K-ATP channel
Congenital Hyperinsulinism: Mutations
Kir6.2 or SUR1 mutation
Congenital Hyperinsulinism: Characterised by what?
Inappropriate and unregulated insulin secretion resulting in severe hypoglycaemia in newborns or children
Congenital Hyperinsulinism: Management
Diazoxide
Diabetic Ketoacidosis
Disordered metabolic state occurring due to absolute or relative insulin deficiency accompanied by an increase in counter-regulatory hormones
Diabetic Ketoacidosis: More commonly a complication of what?
Type I Diabetes Mellitus
Diabetic Ketoacidosis: Increased Insulin Demand - 5 Aetiologies
Infection
Inflammation
Intoxication
Infarction
Iatrogenic
Diabetic Ketoacidosis: Aetiologies - Examples of Infections (3)
Pneumonia
UTI
Cellulitis
Diabetic Ketoacidosis: Aetiologies - Examples of Inflammatory (2)
Pancreatitis
Cholecystitis
Diabetic Ketoacidosis: Aetiologies - Examples of Intoxication (4)
Alcohol
Cocaine
Salicyclate
Methanol
Diabetic Ketoacidosis: Aetiologies - Examples of Iatrogenic causes (2)
Steroids
Surgery
Diabetic Ketoacidosis: Pathophysiology - Ketone bodies are formed where?
Liver mitochondria
Diabetic Ketoacidosis: Pathophysiology - Ketone bodies are important for metabolism where? (2)
Heart
Renal cortex
Diabetic Ketoacidosis: Pathophysiology - When are ketones formed?
If pyruvate or oxalonacetate is limited, excess Acetyl CoA diverted into ketones
Diabetic Ketoacidosis: Pathophysiology - When does this occur?
If insulin supplementation is missed
Diabetic Ketoacidosis: Pathophysiology - Why is it rare in Type II DM?
There is still inhibition of lipolysis
Diabetic Ketoacidosis: Pathophysiology - Why can this occur in starvation?
Oxaloacetate is consumed for gluconeogenesis and when glucose is not available fatty acids are oxidised to provide energy - excess Acetyl-CoA is converted into ketones
Diabetic Ketoacidosis: Clinical Presentation - Osmotic related (2)
Thirst and Polyuria
Dehydration
Diabetic Ketoacidosis: Clinical Presentation - Ketone body related (5)
Flushed
Vomiting
Abdominal pain and tenderness
Increased respiratory rate
Distinct smell on breath
Diabetic Ketoacidosis: Clinical Presentation - Associated conditions (2)
Underlying sepsis
Gastroenteritis
Diabetic Ketoacidosis: Diagnosis - 3 things monitored
Ketonaemia - >3 mmol/L or >2 on urine stick
Blood Glucose - >11
Bicarbonate - <15 mmol/L or venous pH <7.3
Diabetic Ketoacidosis: Diagnosis - Impact on potassium
> 5.5 mmol/L
Diabetic Ketoacidosis: Diagnosis - Creatinine
Increased
Diabetic Ketoacidosis: Diagnosis - Sodium
Reduced
Diabetic Ketoacidosis: Diagnosis - Amylase
Increased - can be due to pancreatitis
Diabetic Ketoacidosis: Diagnosis - WCC
Increased
Diabetic Ketoacidosis: Management - Fluid Losses
1L NaCl 0.9% in the first hour
2L NaCl 0.9% by the end of hour 2
3L NaCl 0.9% by the end of hour 3
Diabetic Ketoacidosis: Management - If blood glucose concentration falls below 14 mmol/L
IV glucose 10% in addition to 0.9% NaCl infusion
Diabetic Ketoacidosis: Management - For electrolyte losses (3)
NaCl 0.9%
IV Potassium
Phosphate replacement - rare
Diabetic Ketoacidosis: Management - Insulin replacement
IV insulin 0.1 units/kg per hour with usual subcutaneous daily basal insulin - continue until ketoacidosis has been resolved
Diabetic Ketoacidosis: Monitoring and timing
Every hour - Blood Ketone and Blood Glucose
Every 2-4 hours - Blood gas and electrolytes
Diabetic Ketoacidosis: Dehydration increases the risk of what?
Thromboembolism
Diabetic Ketoacidosis: Complications - Main one in children
Cerebral oedema
Diabetic Ketoacidosis: Complications - Main ones in adults (3)
Hypokalaemia - can lead to cardiac arrest and paralytic ileus
Aspiration pneumonia
ARDs
Alcoholic Ketoacidosis
Metabolic acidosis caused by increased production of ketone bodies with normal or low glucose levels resulting from alcohol and starvation
Alcoholic Ketoacidosis: Most common patient groups
Malnourished individuals with alcohol dependency
Alcoholic Ketoacidosis: Associated with episodes of what?
Binge drinking with poor food intake, dehydration and vomiting
Alcoholic Ketoacidosis: Why is there an accumulation of ketone bodies? (3)
Depleted glycogen stores in the liver from malnutrition
Increased lipolysis and FFA release
Volume depletion e.g. due to vomiting
Alcoholic Ketoacidosis: Clinical Presentation (4)
Nausea and Vomiting
Abdominal pain
Increased respiratory rate
Dehydration
Alcoholic Ketoacidosis: Management (4)
IV Pabrinex - high dose vitamins with thymine
IV fluids - 5% dextrose in 0.9% NaCl
IV anti-emetics
Insulin occasionally
Alcoholic Ketoacidosis: High dose vitamins used to prevent what?
Wernicke Encephalopathy